The detection of two serologically distinct HLA‐A28 specificities
Identifieur interne : 000834 ( Istex/Curation ); précédent : 000833; suivant : 000835The detection of two serologically distinct HLA‐A28 specificities
Auteurs : D. J. Holmes [États-Unis] ; W. V. Miller [États-Unis] ; G. E. Rodey [États-Unis]Source :
- Tissue Antigens [ 0001-2815 ] ; 1982-03.
Abstract
We describe a serum, 9045, that detects a subset of A28 bearing cells in a mixed population of American blacks, Caucasians of Jewish ancestry and non‐Jewish Caucasians. The serum reacts preferentially with A28 positive cells from American Blacks and Jewish Caucasians and does not react with non‐Jewish Caucasians. This new specificity, referred to as A28.2, is strongly associated with HLA‐B14. In contrast, A28 positive but 9045 negative cells (referred to as A28.1) do not show this association. The A28.2 determinants appears to be antigenically similar to the A28.1 determinant, but distinct from the public antigenic determinants shared by A28, A2, A9 and by A28, Aw33, Aw34 and A26. Based upon this analysis, we conclude that HLA—A28, as defined by most A28 antisera, comprises at least two populations of molecules. The A28.2 form may have arisen in the Mediterranean basin region, whereas the A28.1 form seems to be more prevalent in non‐Jewish Caucasians of Northern European ancestry.
Url:
DOI: 10.1111/j.1399-0039.1982.tb01435.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000834
Links to Exploration step
ISTEX:5436F512DE37D1E0B593432C51A1CF5DF66EE24DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The detection of two serologically distinct HLA‐A28 specificities</title><author><name sortKey="Holmes, D J" sort="Holmes, D J" uniqKey="Holmes D" first="D. J." last="Holmes">D. J. Holmes</name><affiliation wicri:level="1"><mods:affiliation>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD, U.S.A.</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Miller, W V" sort="Miller, W V" uniqKey="Miller W" first="W. V." last="Miller">W. V. Miller</name><affiliation wicri:level="1"><mods:affiliation>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD, U.S.A.</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Rodey, G E" sort="Rodey, G E" uniqKey="Rodey G" first="G. E." last="Rodey">G. E. Rodey</name><affiliation wicri:level="1"><mods:affiliation>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD, U.S.A.</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5436F512DE37D1E0B593432C51A1CF5DF66EE24D</idno><date when="1982" year="1982">1982</date><idno type="doi">10.1111/j.1399-0039.1982.tb01435.x</idno><idno type="url">https://api.istex.fr/document/5436F512DE37D1E0B593432C51A1CF5DF66EE24D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000834</idno><idno type="wicri:Area/Istex/Curation">000834</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The detection of two serologically distinct HLA‐A28 specificities</title><author><name sortKey="Holmes, D J" sort="Holmes, D J" uniqKey="Holmes D" first="D. J." last="Holmes">D. J. Holmes</name><affiliation wicri:level="1"><mods:affiliation>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD, U.S.A.</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Miller, W V" sort="Miller, W V" uniqKey="Miller W" first="W. V." last="Miller">W. V. Miller</name><affiliation wicri:level="1"><mods:affiliation>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD, U.S.A.</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Rodey, G E" sort="Rodey, G E" uniqKey="Rodey G" first="G. E." last="Rodey">G. E. Rodey</name><affiliation wicri:level="1"><mods:affiliation>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD, U.S.A.</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO, the Missouri‐Illinois Regional Red Cross Blood Services, St. Louis, MO, and the American Red Cross Blood Services, Bethesda, MD</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Tissue Antigens</title><idno type="ISSN">0001-2815</idno><idno type="eISSN">1399-0039</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1982-03">1982-03</date><biblScope unit="volume">19</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="161">161</biblScope><biblScope unit="page" to="167">167</biblScope></imprint><idno type="ISSN">0001-2815</idno></series><idno type="istex">5436F512DE37D1E0B593432C51A1CF5DF66EE24D</idno><idno type="DOI">10.1111/j.1399-0039.1982.tb01435.x</idno><idno type="ArticleID">TAN161</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-2815</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We describe a serum, 9045, that detects a subset of A28 bearing cells in a mixed population of American blacks, Caucasians of Jewish ancestry and non‐Jewish Caucasians. The serum reacts preferentially with A28 positive cells from American Blacks and Jewish Caucasians and does not react with non‐Jewish Caucasians. This new specificity, referred to as A28.2, is strongly associated with HLA‐B14. In contrast, A28 positive but 9045 negative cells (referred to as A28.1) do not show this association. The A28.2 determinants appears to be antigenically similar to the A28.1 determinant, but distinct from the public antigenic determinants shared by A28, A2, A9 and by A28, Aw33, Aw34 and A26. Based upon this analysis, we conclude that HLA—A28, as defined by most A28 antisera, comprises at least two populations of molecules. The A28.2 form may have arisen in the Mediterranean basin region, whereas the A28.1 form seems to be more prevalent in non‐Jewish Caucasians of Northern European ancestry.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Informatique/explor/ScrumV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000834 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000834 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Informatique
|area= ScrumV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:5436F512DE37D1E0B593432C51A1CF5DF66EE24D
|texte= The detection of two serologically distinct HLA‐A28 specificities
}}
| This area was generated with Dilib version V0.6.39. |  |